Company Quick10K Filing
Hedgepath Pharmaceuticals
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-05-01
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-07
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-07-23
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-16
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-07-31
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-02-17
10-Q 2016-09-30 Filed 2016-10-31
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-02-01
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-10-10
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-09-06
10-Q 2013-03-31 Filed 2013-05-20
10-K 2013-03-31 Filed 2013-05-20
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-17
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-22
10-Q 2011-03-31 Filed 2011-05-23
10-K 2010-12-31 Filed 2011-05-04
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-10-25
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-06-28 Officers
8-K 2020-06-04
8-K 2020-05-03
8-K 2020-04-10
8-K 2019-12-31
8-K 2019-10-30
8-K 2019-08-21
8-K 2019-08-19
8-K 2019-07-17
8-K 2019-06-30
8-K 2019-06-14
8-K 2019-04-15
8-K 2019-02-11
8-K 2018-12-31
8-K 2018-12-17
8-K 2018-11-05
8-K 2018-07-06
8-K 2018-01-08

Hedgepath Pharmaceuticals Financials

HPPI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Blue Eagle Lithium (BEAG) 23,028 -51.1 -47% 967 634 0 0 -451 -451 23,027
GB Sciences (GBLX) 22,981 -23% -1.8 -56% 29,840 15,525 3,909 -891 -16,597 -12,951 23,417
Reviv3 Procare (RVIV) 28,900 44% -191.0 -20% 741 64 993 440 -150 -150 28,554
Cincinnati Bancorp (CNNB) 22,632 2.8 0% 221,474 197,766 0 0 458 2,707 7,626
Trident Brands (TDNT) 22,618 18% -4.5 -128% 5,394 24,698 2,093 371 -6,884 -4,623 20,964
Synergy CHC (SNYR) 22,472 71% 9.6 11% 16,623 10,696 23,170 16,532 1,894 2,827 27,247
Hedgepath Pharmaceuticals (HPPI) 22,227 -9.9 -141% 1,484 3,359 0 0 -2,098 -2,098 20,855
CafePress (PRSS) 22,127 40% -4.1 -21% 36,635 7,335 76,314 30,369 -7,780 -3,082 12,657
Renmin Tianli (ABAC) 22,074 10% -11.2 1% 90,826 3,425 26,426 2,713 626 3,526 -39,336
Texas Mineral Resources (TMRC) 16,807 -22.5 -194% 383 2,177 0 0 -745 -745 16,788
Precision Optics (PEYE) 21,877 34% -59.2 -7% 6,037 2,591 7,760 2,634 -402 -355 21,028
flooidCX (GRPV) 21,817 -11.2 -4,072% 48 3,441 0 0 -1,947 -1,947 21,806
Non Invasive Monitoring Systems (NIMU) 21,673 -14.9 -434% 337 311 0 0 -1,463 -1,429 21,340
Franklin Wireless (FKWL) 21,669 15% -17.0 -5% 21,195 5,921 30,018 4,363 -1,120 -898 15,221
Quantum Materials (QTMM) 21,666 0% -3.0 -359% 2,067 7,192 8 0 -7,413 -7,145 21,531
Newbridge Global Ventures (NBGV) 21,547 0% -3.6 -31% 22,306 9,397 10 0 -6,974 -6,498 23,224
Velt (VIGC) 21,528 100% -19.3 -9% 12,999 120 6 6 -1,115 -1,115 21,524
Rego Payment Architectures (RPMT) 21,527 0% -11.5 -466% 511 22,392 34 0 -2,384 -1,869 21,505
Central Federal Bancshares (CFDB) 21,504 55.7 0% 69,041 43,820 0 0 47 301 16,775

Balance Sheet ($'000)2013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash000271376365841,8941,2436011194,6153,5546,8852,3401,6438873441,5737961,4411,1091,1312,0251,372
Accounts Receivable
Inventory
PP&E0
Assets010103014234631282,1901,5508864214,9153,8637,3382,7752,0611,3097681,9801,1841,8331,2331,2532,1321,484
Accounts Payable233287355280331325494246442383647396441298340322219535370326328385245195286
Long-Term Debt
Liabilities5517769734544334015694135404627436184703083963402526014414625491,2011,8253,3053,359
Stockholders' Equity-551-766-962-153-1062-4411,7771,009424-3234,2973,3937,0302,3791,7221,0571671,538-1,638-2,67732-572-1,173-1,875
Income Statement ($'000)2013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000000000000000
Cost of Revenue
Gross Profit
R&D1,05015251,930167308313300602465583606720733818441434535674769775197304364
SG&A2421981621855715896104916005686127251,0142,0301,995279248370501609400595332318
Tax
Net Income-1,292-215-196-2,141-740-898-923-792-1,202-1,033-1,194-1,329-1,725-2,752-2,801-716-679-904-1,171-882-1,172-786-633-679
Cash Flow ($'000)2013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-169-109-294-382-519-281-690-650-642-483-1,005-1,061-1,210-868-746-756-543-1,132-955-978-606-554
Cash Investing
Cash Financing1701095654875080004,541-3,67850002,3611,6001,0001,500-99